Efficacy and safety of bevacizumab in Chinese patients with metastatic colorectal cancer.

MLA

Zhu, Li-Ming, et al. “Efficacy and Safety of Bevacizumab in Chinese Patients with Metastatic Colorectal Cancer.” Asian Pacific Journal of Cancer Prevention : APJCP, vol. 15, no. 16, 2014, pp. 6559–64. EBSCOhost, https://doi.org/10.7314/apjcp.2014.15.16.6559.

APA

Zhu, L.-M., Zhao, Y.-Z., Ju, H.-X., Liu, L.-Y., Chen, L., Liu, B.-X., Xu, Q., Luo, C., Ying, J.-E., Yang, Y.-S., & Zhong, H.-J. (2014). Efficacy and safety of bevacizumab in Chinese patients with metastatic colorectal cancer. Asian Pacific Journal of Cancer Prevention : APJCP, 15(16), 6559–6564. https://doi.org/10.7314/apjcp.2014.15.16.6559

Chicago

Zhu, Li-Ming, Ya-Zhen Zhao, Hai-Xing Ju, Lu-Ying Liu, Lei Chen, Bi-Xia Liu, Qi Xu, et al. 2014. “Efficacy and Safety of Bevacizumab in Chinese Patients with Metastatic Colorectal Cancer.” Asian Pacific Journal of Cancer Prevention : APJCP 15 (16): 6559–64. doi:10.7314/apjcp.2014.15.16.6559.